
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 27 years ago
Coronary Heart Disease in the United Statesover 27 years ago
Mechanisms of Acute Coronary Eventsover 27 years ago
Primary Preventionover 27 years ago
Pravastatin Event Reduction Analysisover 27 years ago
Secondary Preventionover 27 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?over 27 years ago
Methods and Mindsets in Pharmacoeconomicsover 27 years ago
Issues and Controversies in Pharmacoeconomicsover 27 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
3
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
4
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
5















































